May 9, 2014
Dr. Chi Tonglien Viet, an investigator and adjunct professor of oral and maxillofacial surgery at the New York University College of Dentistry, was awarded the International Association for the Study of Pain (IASP) Early Career Research Grant to support her study entitled “Mechanisms of OPRM1 Regulation in Head and Neck Cancer Pain.” Dr. Viet was among 43 investigators from 16 countries to apply for the IASP Early Career Research Grant, which was awarded to a total of eight applicants. Dr. Viet was one of two principal investigators from the United States to receive this honor. The study will be conducted at the NYU Bluestone Center for Clinical Research and the NYU Cancer Pain Laboratory.
Patients with head and neck cancer suffer from severe pain that reduces their quality of life. Opioids such as morphine are the most effective treatment for head and neck cancer pain, but are ineffective in a subset of patients. Dr. Viet will explore the effect of genetic variants of the mu-opioid receptor, which binds opioids, on opioid response in head and neck cancer patients. These findings could help identify those head and neck cancer patients who respond poorly to opioids and might need additional, tailored pain relief regimens.
Dr. Chi Tonglien Viet is a fourth-year resident in the Oral and Maxillofacial Surgery at NYU. She is an investigator at the NYU Bluestone Center for Clinical Research and Cancer Pain Laboratory. She received her DDS and PhD degrees from the University of California, San Francisco, and her MD degree from New York University.
About the International Association for the Study of Pain --The IASP is a leading professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain and to translate that knowledge into improved pain relief worldwide.
About the NYU Cancer Pain Laboratory--The NYU Cancer Pain Laboratory has recruited, trained, and promoted a handful of gifted investigators to investigate neuronal mechanisms of cancer pain. Much of our research utilizes preclinical models of oral cancer, most notably, squamous cell carcinoma. Our researchers pursue studies on the interaction between squamous cell carcinoma and peripheral afferent fibers in the cancer microenvironment. In cell based research as well as studies that employ patient specimens we seek to leverage scientific discovery for improved patient care.
About the Bluestone Center for Clinical Research--The Bluestone Center for Clinical Research, in conjunction with the NYU Oral Cancer Center, is an academic research organization located at the NYU College of Dentistry. Bluestone’s mission is to take a creative scientific approach to transform world health. Bluestone is dedicated to conducting research in oral cancer, cancer symptomology, pharmaceuticals, medical devices, emerging biotechnology, periodontics, implants, and oral health products.